Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome

被引：48
作者：
Duncan G.E. [1 ]
机构：
[1] Interdisciplinary Graduate Program in Nutritional Sciences, Department of Epidemiology, University of Washington, Seattle, WA 98195
来源：
Current Diabetes Reports | 2006年 / 6卷 / 1期
关键词：
Physical Activity; Metabolic Syndrome; Impaired Fasting Glucose; Diabetes Prevention Program; Cardiovascular Disease Risk Factor;
D O I：
10.1007/s11892-006-0048-1
中图分类号：
学科分类号：
摘要：
This article highlights research supporting the concept that increased physical activity and cardiorespiratory fitness attenuate risk of cardiovascular disease, type 2 diabetes, and the metabolic syndrome. Increased activity and fitness also attenuate risk of developing cardiovascular disease in persons who have type 2 diabetes or the metabolic syndrome. Although controversial, relationships between physical activity/physical fitness and type 2 diabetes/metabolic syndrome are largely independent of body weight. Thus, physical inactivity and poor cardiorespiratory fitness are not only important determinants of cardiovascular and metabolic diseases, but they can also be considered common features of these conditions, much like traditional risk factors such as obesity and insulin resistance. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：29 / 35
页数：6
相关论文
共 54 条
  • [1] National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2003, National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003, (2004)
  • [2] Kannel W.B., McGee D.L., Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study, Diabetes Care, 2, pp. 120-126, (1979)
  • [3] Kannel W.B., D'Agostino R.B., Wilson P.W., Et al., Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience, Am Heart J, 120, pp. 672-676, (1990)
  • [4] Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, pp. 2486-2497, (2001)
  • [5] Alberti G., IDF consensus on the metabolic syndrome: Definition and treatment, (2005)
  • [6] Ford E.S., Giles W.H., Dietz W.H., Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey, JAMA, 287, pp. 356-359, (2002)
  • [7] Park Y.W., Zhu S., Palaniappan L., Et al., The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994, Arch Intern Med, 163, pp. 427-4736, (2003)
  • [8] Hanson R.L., Imperatore G., Bennett P.H., Knowler W.C., Components of the "metabolic syndrome" and incidence of type 2 diabetes, Diabetes, 51, pp. 3120-3127, (2002)
  • [9] Laaksonen D.E., Lakka H.M., Niskanen L.K., Et al., Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study, Am J Epidemiol, 156, pp. 1070-1077, (2002)
  • [10] Lorenzo, Okoloise M., Williams K., Et al., The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study, Diabetes Care, 26, pp. 3153-3159, (2003)
123456